From post

(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors

, , , , , , , , , и . Mol Pharmacol, 57 (5): 968-75 (мая 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells, , , , , , , , и . J Invest Dermatol, 119 (4): 923-33 (октября 2002)Merighi, Stefania Mirandola, Prisco Milani, Daniela Varani, Katia Gessi, Stefania Klotz, Karl-Norbert Leung, Edward Baraldi, Pier Giovanni Borea, Pier Andrea United States The Journal of investigative dermatology J Invest Dermatol. 2002 Oct;119(4):923-33..Synthesis, biological activity, and molecular modeling investigation of new pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as human A(3) adenosine receptor antagonists, , , , , , , , , и . J Med Chem, 45 (4): 770-80 (февраля 2002)Baraldi, Pier Giovanni Cacciari, Barbara Moro, Stefano Spalluto, Giampiero Pastorin, Giorgia Da Ros, Tatiana Klotz, Karl-Norbert Varani, Katia Gessi, Stefania Borea, Pier Andrea Research Support, Non-U.S. Gov't United States Journal of medicinal chemistry J Med Chem. 2002 Feb 14;45(4):770-80..Binding thermodynamics at the human A(3) adenosine receptor, , , , , , и . Biochem Pharmacol, 63 (2): 157-61 (января 2002)Merighi, Stefania Varani, Katia Gessi, Stefania Klotz, Karl Norbert Leung, Edward Baraldi, Pier Giovanni Borea, Pier Andrea England Biochemical pharmacology Biochem Pharmacol. 2002 Jan 15;63(2):157-61..(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors, , , , , , , , , и . Mol Pharmacol, 57 (5): 968-75 (мая 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..Adenosine receptors and cancer, , , , , , и . Handb Exp Pharmacol, (2009)Fishman, P Bar-Yehuda, S Synowitz, M Powell, J D Klotz, K N Gessi, S Borea, P A Review Germany Handbook of experimental pharmacology Handb Exp Pharmacol. 2009;(193):399-441..Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, 3HMRE 2029-F20, , , , , , , , , и 2 other автор(ы). Mol Pharmacol, 67 (6): 2137-47 (июня 2005)Gessi, Stefania Varani, Katia Merighi, Stefania Cattabriga, Elena Pancaldi, Cecilia Szabadkai, Youri Rizzuto, Rosario Klotz, Karl-Norbert Leung, Edward Mac Lennan, Stephen Baraldi, Pier Giovanni Borea, Pier Andrea Comparative Study United States Molecular pharmacology Mol Pharmacol. 2005 Jun;67(6):2137-47. Epub 2005 Mar 23..Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors, , , , , , , , , и 2 other автор(ы). Biochem Pharmacol, 70 (11): 1601-12 (ноября 2005)Varani, Katia Gessi, Stefania Merighi, Stefania Vincenzi, Fabrizio Cattabriga, Elena Benini, Annalisa Klotz, Karl-Norbert Baraldi, Pier Giovanni Tabrizi, Mojgan Aghazadeh Lennan, Stephen Mac Leung, Edward Borea, Pier Andrea England Biochemical pharmacology Biochem Pharmacol. 2005 Nov 25;70(11):1601-12. Epub 2005 Oct 10..Pyrazolo4,3-e1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen, , , , , , , , , и 1 other автор(ы). J Med Chem, 43 (25): 4768-80 (декабря 2000)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Moro, S Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 2000 Dec 14;43(25):4768-80..Pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists, , , , , , , , , и . J Med Chem, 42 (22): 4473-8 (ноября 1999)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A In Vitro Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 1999 Nov 4;42(22):4473-8..